Lung cancer drug response tied to tumor type: study
Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for successful treatment, according to results from a recent trial.
Read more on Reuters via Yahoo! News
CTRC commences enrollment in Phase 2 trial of REOLYSIN combination for SCC lung cancer
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous …
Read more on News-Medical-Net
Product Description
Consistent with the plant-based diet recommended by the American Cancer Society, this book summarizes, in plain English, the latest findings from scientific studies related to genetic triggers, and other complex factors now known to influence health. Delicious and healthy food can be a part of your lifestyle today, if you know how to choose what’s good for you…. More >>